Fleming R, Black W P, Coutts J R
Clin Endocrinol (Oxf). 1985 Dec;23(6):683-8. doi: 10.1111/j.1365-2265.1985.tb01129.x.
A LH-releasing hormone (LHRH) analogue was administered to subjects with elevated circulating LH concentrations and elevated androgens (polycystic ovary syndrome, PCO) and also to a control group with normal menstrual rhythm and normal LH and androgens. In both groups circulating LH concentrations were reduced to low and indistinguishable concentrations. Oestradiol, oestrone, androstenedione and testosterone levels were all reduced by treatment in both groups. However, the reduction in androgen concentrations was less marked in the patients with PCO. The oestrogen/androgen ratios remained relatively unaltered, but the testosterone levels remained slightly elevated in the PCO patients after treatment. The results suggest that patients with PCO syndrome show a disorder of androgen metabolism independent of elevated LH concentrations.
对循环中促黄体生成素(LH)浓度升高且雄激素水平升高的受试者(多囊卵巢综合征,PCO)以及月经周期正常且LH和雄激素水平正常的对照组给予促黄体生成素释放激素(LHRH)类似物。在两组中,循环中的LH浓度均降至较低且难以区分的水平。两组中雌二醇、雌酮、雄烯二酮和睾酮水平均因治疗而降低。然而,PCO患者的雄激素浓度降低不太明显。雌激素/雄激素比值相对保持不变,但PCO患者治疗后睾酮水平仍略有升高。结果表明,PCO综合征患者存在独立于LH浓度升高的雄激素代谢紊乱。